Loading compound...
Small molecule inhibitor
Solcitinib is an experimental small molecule drug currently being studied in clinical trials. It is being investigated for its potential to treat inflammatory conditions such as systemic lupus erythematosus, psoriasis, and ulcerative colitis.
How it worksSolcitinib is a small molecule that interacts with various biological targets to potentially manage inflammation.
Used for
systemic lupus erythematosuspsoriasisulcerative colitis
Conditions
systemic lupus erythematosuspsoriasisulcerative colitis
Class
small moleculeSmall molecule inhibitorimmune system
How to take
This drug is currently in the research phase (clinical trials) and is not yet approved for general use by regulatory agencies like the FDA for any specific condition listed above.
Talk to your doctor
Questions to ask
- ·Is Solcitinib part of any clinical trials I might qualify for?
- ·How does Solcitinib work differently than my current treatment?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.
